Skip to main content

UroGen Pharma Ltd.

URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001668243

In the last 90 days, UroGen Pharma Ltd. insiders filed 0 open-market purchases and 4 sales; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.56B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q3 2023

Institutional positions in UroGen Pharma Ltd. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
101
+16 vs. Q2 2023
Shares held
17.7M
+4.41M (+33.1%) vs. Q2 2023
Total value
$248.3M
+$110.5M (+80.2%) vs. Q2 2023
New holders
24
35 more added
Sold out
8
22 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting URGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 101 institutions
Q1 2021: 89 institutionsQ2 2021: 82 institutionsQ3 2021: 93 institutionsQ4 2021: 78 institutionsQ1 2022: 84 institutionsQ2 2022: 65 institutionsQ3 2022: 60 institutionsQ4 2022: 64 institutionsQ1 2023: 66 institutionsQ2 2023: 85 institutionsQ3 2023: 101 institutionsQ4 2023: 105 institutionsQ1 2024: 112 institutionsQ2 2024: 115 institutionsQ3 2024: 128 institutionsQ4 2024: 138 institutionsQ1 2025: 140 institutionsQ2 2025: 150 institutionsQ3 2025: 161 institutionsQ4 2025: 167 institutionsQ1 2026: 173 institutionsQ2 2026: 190 institutions
Value heldQ3 2023: $248.3M
Q1 2021: $278.5MQ2 2021: $213.7MQ3 2021: $236.9MQ4 2021: $140.4MQ1 2022: $123.9MQ2 2022: $109.2MQ3 2022: $110.8MQ4 2022: $115.4MQ1 2023: $116.1MQ2 2023: $137.8MQ3 2023: $248.3MQ4 2023: $321.2MQ1 2024: $407.4MQ2 2024: $641.4MQ3 2024: $445.7MQ4 2024: $386.3MQ1 2025: $460.6MQ2 2025: $545.2MQ3 2025: $878.6MQ4 2025: $1.02BQ1 2026: $835.2MQ2 2026: $1.56B
Institutions holding URGN and their total value by quarter
QuarterHoldersValue
Q2 2026190$1.56B
Q1 2026173$835.2M
Q4 2025167$1.02B
Q3 2025161$878.6M
Q2 2025150$545.2M
Q1 2025140$460.6M
Q4 2024138$386.3M
Q3 2024128$445.7M
Q2 2024115$641.4M
Q1 2024112$407.4M
Q4 2023105$321.2M
Q3 2023101$248.3M
Q2 202385$137.8M
Q1 202366$116.1M
Q4 202264$115.4M
Q3 202260$110.8M
Q2 202265$109.2M
Q1 202284$123.9M
Q4 202178$140.4M
Q3 202193$236.9M
Q2 202182$213.7M
Q1 202189$278.5M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding UroGen Pharma Ltd.; share changes are against Q2 2023.

Institutions holding URGN in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Great Point Partners LLC2,620,545$36.7M6.91%+2,620,545New
Stonepine Capital Management, LLC0$00.00%−448,508−100.0%Sold out
Cerity Partners LLC0$00.00%−125,226−100.0%Sold out
Eversept Partners, LP0$00.00%−74,797−100.0%Sold out
XTX Topco Ltd0$00.00%−23,323−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−15,200−100.0%Sold out
Trexquant Investment LP0$00.00%−14,763−100.0%Sold out
Squarepoint Ops LLC0$00.00%−10,920−100.0%Sold out
Cutler Group LP0$00.00%−400−100.0%Sold out